Search

    Language Settings
    Select Website Language

    GDPR Compliance

    We use cookies to ensure you get the best experience on our website. By continuing to use our site, you accept our use of cookies, Privacy Policy, and Terms of Service.

    BijnorNews
    Bijnor news

    Divi's Labs In Focus: Citi Reaffirms 'Buy' With Rs 11,700 Target On Oral Wegovy Upside

    1 day ago

    Citi said Divi's has an integrated and cost-efficient peptide manufacturing platform, which could provide an advantage as demand for peptide-based therapies expands.
    Click here to Read More
    Previous Article
    No Sudden Jolt At 320 Kmph: How India's Bullet Train Will Switch Tracks
    Next Article
    Irumudi Box Office Day 33: Film Enters Final Leg, Eyes Rs 200 Crore Mark

    Related Trending Stories Updates:

    Are you sure? You want to delete this comment..! Remove Cancel

    Comments (0)

      Leave a comment